Sabra Health Care REIT stock carries a 6.1 percent yield

Published on 10/04/2026 at 10:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sabra Health Care REIT stock stood at USD 19.16 on October 2, 2026, on Nasdaq. Q2 2026 revenue rose 24.7 percent, while diluted EPS came in at negative USD 0.10.

SBRA, US78573L1061, Illustration mit AI erstellt.

Sabra Health Care REIT stock (ISIN US78573L1061) closed at USD 19.16 on Nasdaq on October 2, 2026, down 0.21 percent from the prior close. The latest operating picture combines 24.7 percent year-over-year revenue growth with a diluted EPS loss of USD 0.10 in Q2 2026.

Revenue beats while EPS misses

According to MarketBeat, Sabra generated USD 230.11 million of revenue in Q2 2026, compared with USD 219.39 million expected by analysts. Revenue increased 24.7 percent from the same quarter a year earlier, but diluted EPS of negative USD 0.10 missed the USD 0.17 consensus by USD 0.27.

The contrast matters for a healthcare REIT: top-line expansion did not translate into positive GAAP earnings for the quarter. Sabra also maintained a quarterly dividend of USD 0.30, paid on August 31, 2026, equivalent to a reported 6.1 percent annualized yield, according to MarketBeat.

Guidance keeps the operating case alive

Sabra's September 9, 2026 investor presentation retained 2026 normalized FFO guidance of USD 1.53-1.55 per diluted share and normalized AFFO guidance of USD 1.59-1.61, as reported by MarketScreener. The guidance gives investors a cash-flow measure alongside the quarter's negative GAAP EPS.

The company said in a September 9, 2026 business update that it owns and invests in healthcare real estate across the United States and Canada, while management was scheduled to participate in the BofA Securities 2026 Global Real Estate Conference, according to Business Wire.

Analysts see room above USD 19.16

MarketBeat reported a Moderate Buy consensus from 14 brokerages and an average 12-month price target of USD 22.23. That target lies 16.0 percent above the October 2, 2026 Nasdaq closing price, while seven analysts rated the shares Buy and seven rated them Hold.

SBRA trades below its yearly high

SBRA closed at USD 19.16 on Nasdaq on October 2, 2026, with volume of 3,008,372 shares and a market capitalization of USD 4.8 billion. The 52-week range was USD 17.17 to USD 22.77, placing the stock USD 3.61 below its yearly high.